68 related articles for article (PubMed ID: 19420968)
1. Where do we place PankoMab in the reagents used to study the MUC1 superfamily?
Li J; Sullivan CA; Harris L
Onkologie; 2009 May; 32(5):235-7. PubMed ID: 19420968
[No Abstract] [Full Text] [Related]
2. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.
Dian D; Janni W; Kuhn C; Mayr D; Karsten U; Mylonas I; Friese K; Jeschke U
Onkologie; 2009 May; 32(5):238-44. PubMed ID: 19420969
[TBL] [Abstract][Full Text] [Related]
3. Protein Z-dependent protease inhibitor (ZPI) is present in loco in human breast cancer tissue.
Sierko E; Wojtukiewicz MZ; Ostrowska-Cichocka K; Zimnoch L
Thromb Haemost; 2010 Jul; 104(1):183-5. PubMed ID: 20458435
[No Abstract] [Full Text] [Related]
4. Cytoplasmic MUC1 in PanIN-1.
Bara J; Forgue-Lafitte ME
Clin Cancer Res; 2008 Aug; 14(16):5306; author reply 5306-7. PubMed ID: 18698052
[No Abstract] [Full Text] [Related]
5. Are invasive micropapillary carcinomas of breast really composed of papillae?
Patriarca C; Giunta P
Int J Surg Pathol; 2009 Aug; 17(4):354. PubMed ID: 19625258
[No Abstract] [Full Text] [Related]
6. Combination of immunohistochemistry and laser ablation ICP mass spectrometry for imaging of cancer biomarkers.
Seuma J; Bunch J; Cox A; McLeod C; Bell J; Murray C
Proteomics; 2008 Sep; 8(18):3775-84. PubMed ID: 18712769
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.
Heublein S; Mayr D; Egger M; Karsten U; Goletz S; Angele M; Gallwas J; Jeschke U; Ditsch N
J Exp Clin Cancer Res; 2015 May; 34(1):50. PubMed ID: 25986064
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer: search for new targets and improvement of existing techniques.
Bharath R; Parikh PM
Indian J Cancer; 2010; 47(2):95-7. PubMed ID: 20448369
[No Abstract] [Full Text] [Related]
9. [Immunohistochemical diagnosis in breast cancers].
Czerwenka K
Gynakol Rundsch; 1988; 28(2):116-9. PubMed ID: 3402822
[No Abstract] [Full Text] [Related]
10. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
Moriya T; Kanomata N; Kozuka Y; Fukumoto M; Iwachido N; Hata S; Takahashi Y; Miura H; Ishida K; Watanabe M
Breast Cancer; 2009; 16(3):173-8. PubMed ID: 19475479
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma.
Ando H; Aihara R; Ohno T; Ogata K; Mochiki E; Kuwano H
Br J Surg; 2009 Aug; 96(8):901-9. PubMed ID: 19591170
[TBL] [Abstract][Full Text] [Related]
12. Validation of activated caspase-3 antibody staining as a marker of apoptosis in breast cancer.
Sabine VS; Faratian D; Kirkegaard-Clausen T; Bartlett JM
Histopathology; 2012 Jan; 60(2):369-71. PubMed ID: 22168172
[No Abstract] [Full Text] [Related]
13. KL-6 mucin in metastatic liver cancer tissues from primary colorectal carcinoma.
Zhang K; Tang W; Qu X; Guo Q; Inagaki Y; Seyama Y; Abe H; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Hepatogastroenterology; 2009; 56(93):960-3. PubMed ID: 19760920
[TBL] [Abstract][Full Text] [Related]
14. Intraductal tubulopapillary neoplasm of the pancreatic branch duct showing atypical images.
Yoshida Y; Matsubayashi H; Sasaki K; Kanemoto H; Uesaka K; Ono H
J Dig Dis; 2015 Jun; 16(6):357-61. PubMed ID: 25761758
[No Abstract] [Full Text] [Related]
15. Significance of MUC1 in bladder cancer.
Ahmad S; Lam TB; N'Dow J
BJU Int; 2015 Jan; 115(1):161-2. PubMed ID: 24593053
[No Abstract] [Full Text] [Related]
16. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection.
Li Y; Xu J; Chen L; Zhong WD; Zhang Z; Mi L; Zhang Y; Liao CG; Bian HJ; Jiang JL; Yang XM; Li XY; Fan CM; Zhu P; Fu L; Chen ZN
Histopathology; 2009 May; 54(6):677-87. PubMed ID: 19438743
[TBL] [Abstract][Full Text] [Related]
17. High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.
Bielsa S; Esquerda A; Salud A; Montes A; Arellano E; Rodríguez-Panadero F; Porcel JM
Eur J Intern Med; 2009 Jul; 20(4):383-6. PubMed ID: 19524179
[TBL] [Abstract][Full Text] [Related]
18. A comparison of estrogen receptor SP1 and 1D5 monoclonal antibodies in routine clinical use reveals similar staining results.
Brock JE; Hornick JL; Richardson AL; Dillon DA; Lester SC
Am J Clin Pathol; 2009 Sep; 132(3):396-401. PubMed ID: 19687316
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.
Raica M; Cîmpean AM; Meche A; Alexa A; Suciu C; Mureşan A
Rom J Morphol Embryol; 2009; 50(3):341-7. PubMed ID: 19690758
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic pitfalls in mammary pathology. Case 8. Breast metastases of a malignant melanoma].
Dauplat MM; Penault-Llorca F
Ann Pathol; 2009 Jun; 29(3):228-32. PubMed ID: 19619831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
